𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical utility of tumor markers in hepatocellular and pancreatic carcinomas

✍ Scribed by Takami, Hiroshi ;Takada, Tadahiro

Publisher
Springer
Year
1995
Tongue
English
Weight
953 KB
Volume
2
Category
Article
ISSN
0944-1166

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clinical use of tumor markers in pancrea
Clinical use of tumor markers in pancreatic carcinoma
✍ Maureen A. Chung; Helena R. Chang πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 473 KB

There is no ideal tumor marker for pancreatic carcinoma. Most of the tumor-associated antigens in this disease are cell surface mucins, such as CA19-9, TAG-72, CA242, CA50, CA195, and CA494. CA19-9 is the most promising marker. It is used for clinical and pathological diagnosis, prognosis, and respo

IGFBP7 downregulation is associated with
IGFBP7 downregulation is associated with tumor progression and clinical outcome in hepatocellular carcinoma
✍ Yoshito Tomimaru; Hidetoshi Eguchi; Hiroshi Wada; Shogo Kobayashi; Shigeru Marub πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 French βš– 768 KB

## Abstract Insulin‐like growth factor‐binding protein 7 (IGFBP7) functions in several cellular processes including proliferation, senescence and apoptosis. This study analyzed IGFBP7 function in hepatocellular carcinoma (HCC) cells by gene manipulation and investigated the prognostic significance